Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling

BACKGROUND: Only a minority of patients with advanced non-small cell lung cancer (NSCLC) benefit from chemotherapy. Serum peptide profiling of NSCLC patients was performed to investigate patterns associated with treatment outcome. Using magnetic bead-assisted serum peptide capture coupled to matrix-...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Voortman, Johannes, Pham, Thang V, Knol, Jaco C, Giaccone, Giuseppe, Jimenez, Connie R
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2009
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2746186/
https://ncbi.nlm.nih.gov/pubmed/19728888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-5956-7-34
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items